LIVIVO - Search results -

Search results

Result 1 - 10 of total 244

Search options

Article ; Online: The neuropsychiatric effects of vitamin C deficiency: a systematic review.

Plevin, David / Galletly, Cherrie

BMC psychiatry

2020 Volume 20, Issue 1, Page(s) 315

Abstract: Background: Vitamin C deficiency may be more common than is generally assumed, and the association ... between vitamin C deficiency and adverse psychiatric effects has been known for centuries. This paper aims ... to systematically review the evidence base for the neuropsychiatric effects of vitamin C deficiency.: Methods ...

Abstract	Background: Vitamin C deficiency may be more common than is generally assumed, and the association between vitamin C deficiency and adverse psychiatric effects has been known for centuries. This paper aims to systematically review the evidence base for the neuropsychiatric effects of vitamin C deficiency. Methods: Relevant studies were identified via systematic literature review. Results: Nine studies of vitamin C deficiency, including subjects both with and without the associated physical manifestations of scurvy, were included in this review. Vitamin C deficiency, including scurvy, has been linked to depression and cognitive impairment. No effect on affective or non-affective psychosis was identified. Conclusions: Disparate measurement techniques for vitamin C, and differing definitions of vitamin C deficiency were apparent, complicating comparisons between studies. However, there is evidence suggesting that vitamin C deficiency is related to adverse mood and cognitive effects. The vitamin C blood levels associated with depression and cognitive impairment are higher than those implicated in clinical manifestations of scurvy. While laboratory testing for ascorbic acid can be practically difficult, these findings nonetheless suggest that mental health clinicians should be alerted to the possibility of vitamin C deficiency in patients with depression or cognitive impairment. Vitamin C replacement is inexpensive and easy to deliver, although as of yet there are no outcome studies investigating the neuropsychiatric impact of vitamin C replacement in those who are deficient.
MeSH term(s)	Ascorbic Acid/blood ; Ascorbic Acid Deficiency/blood ; Ascorbic Acid Deficiency/complications ; Ascorbic Acid Deficiency/physiopathology ; Ascorbic Acid Deficiency/psychology ; Cognitive Dysfunction/blood ; Cognitive Dysfunction/etiology ; Cognitive Dysfunction/physiopathology ; Cognitive Dysfunction/psychology ; Depression/blood ; Depression/complications ; Depression/physiopathology ; Depression/psychology ; Humans ; Scurvy/blood ; Scurvy/complications ; Vitamins/blood
Chemical Substances	Vitamins ; Ascorbic Acid (PQ6CK8PD0R)
Language	English
Publishing date	2020-06-18
Publishing country	England
Document type	Journal Article ; Systematic Review
ISSN	1471-244X
ISSN (online)	1471-244X
DOI	10.1186/s12888-020-02730-w
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls.

Jacomb, Isabella / Stanton, Clive / Vasudevan, Rohini / Powell, Hugh / O'Donnell, Maryanne / Lenroot, Rhoshel / Bruggemann, Jason / Balzan, Ryan / Galletly, Cherrie / Liu, Dennis / Weickert, Cynthia S / Weickert, Thomas W

Frontiers in immunology

2018 Volume 9, Page(s) 2230

Abstract: ... we assessed the peripheral inflammation marker C-reactive protein (CRP) to determine the extent to which: (1 ...

Abstract	There is increasing evidence for the role of inflammation in schizophrenia, yet the stability of increased peripheral inflammation in acute psychosis and the degree to which peripheral inflammation relates to cortical thickness, a measure of the degree of neuropathology, are unknown. In independent samples, we assessed the peripheral inflammation marker C-reactive protein (CRP) to determine the extent to which: (1) CRP was elevated and stable across admissions for acute psychosis, (2) cognition, daily function and symptom severity are characteristic of chronically ill patients with schizophrenia displaying elevated CRP, and (3) CRP levels predict cortical thickness. Study 1 assessed peripheral CRP (primary outcome) and other blood measures in 174/280 people with acute psychosis while Study 2 assessed peripheral CRP, cognition and cortical thickness (primary outcomes), symptoms, and daily function in 85/97 chronically ill patients with schizophrenia and 71/87 healthy controls. In acute psychosis, CRP and neutrophil-to-lymphocyte ratio were significantly elevated relative to a normal cutoff (with 59.8% of patients having elevated CRP) which remained elevated across admissions. CRP was significantly elevated in 43% of chronically ill patients with schizophrenia compared to 20% in controls. Elevated CRP patients displayed significantly worse working memory and CRP was inversely correlated with cortical thickness in frontal, insula, and temporal brain regions. This work supports the role of inflammation in psychotic illnesses and suggests that use of peripheral markers (e.g., CRP) in conjunction with diagnosis could be used to identify patients with more cortical neuropathology and cognitive deficits.
MeSH term(s)	Adult ; Antipsychotic Agents/therapeutic use ; C-Reactive Protein/immunology ; C-Reactive Protein/metabolism ; Cerebral Cortex/diagnostic imaging ; Cerebral Cortex/immunology ; Cerebral Cortex/metabolism ; Female ; Humans ; Inflammation/drug therapy ; Inflammation/immunology ; Inflammation/metabolism ; Magnetic Resonance Imaging/methods ; Male ; Middle Aged ; Psychotic Disorders/drug therapy ; Psychotic Disorders/immunology ; Psychotic Disorders/metabolism ; Schizophrenia/drug therapy ; Schizophrenia/immunology ; Schizophrenia/metabolism
Chemical Substances	Antipsychotic Agents ; C-Reactive Protein (9007-41-4)
Language	English
Publishing date	2018-10-10
Publishing country	Switzerland
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	2606827-8
ISSN	1664-3224 ; 1664-3224
ISSN (online)	1664-3224
ISSN	1664-3224
DOI	10.3389/fimmu.2018.02230
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Associations between health literacy, cognitive function and general literacy in people with schizophrenia attending community mental health clinics in Australia.

Thomson, Sumana / Galletly, Cherrie / Prener, Christopher / Garverich, Suzanne / Liu, Dennis / Lincoln, Alisa

BMC psychiatry

2022 Volume 22, Issue 1, Page(s) 245

Abstract: Background: Health literacy (HL) has been defined as the ability of individuals to access, understand, and utilise basic health information. HL is crucial to patient engagement in treatment through supporting patient autonomy, informed consent and ... ...

Abstract	Background: Health literacy (HL) has been defined as the ability of individuals to access, understand, and utilise basic health information. HL is crucial to patient engagement in treatment through supporting patient autonomy, informed consent and collaborative care. In people with physical disorders, poor HL is associated with poor health outcomes, but less is known about HL in people with severe mental illness. This study aimed to assess HL and investigate the associations between education, cognitive function, general literacy, and HL in participants with schizophrenia attending community mental health clinics. Method: Fifty-two outpatients with schizophrenia attending a public community mental health clinic in Adelaide, Australia completed the Test of Functional Health Literacy in Adults-Short Form (S-TOFHLA) along with tests of cognition, aural and reading literacy and numeracy including Digit Symbol Coding (DSC), verbal fluency, the Wechsler Adult Intelligence Scale (WAIS-IV), Woodcock-Johnson III (Part 4 and 9) and the Lipkus numeracy scale. Sixty-one percent of participants were male. Participants had a mean age of 41.2 (SD 9.9) years and a mean of 11.02 (SD 1.5) years of education. Results: The majority of participants had very poor aural and verbal literacy and poorer literacy correlated with fewer years of education. On the S-TOFHLA, 81% of participants had adequate HL; 6% were marginal and 13% were inadequate. There was a positive correlation between education and HL, with those with more years of education scoring higher for HL. There was also a significant association between better HL and better working memory and attention. Conclusions: Consistent with previous research in schizophrenia, our participants had reduced educational attainment, aural and reading literacy and cognitive function compared to population norms. However, HL was better than expected given that previous research has found that people with psychiatric disorders tend to have lower HL, compared to the general population. This may reflect effective case management of our participants whilst attending the community clinics and supports ongoing research and intervention regarding HL in people living with mental illness.
MeSH term(s)	Adult ; Cognition ; Educational Status ; Health Literacy ; Humans ; Male ; Mental Health ; Schizophrenia/therapy
Language	English
Publishing date	2022-04-07
Publishing country	England
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	2050438-X
ISSN	1471-244X ; 1471-244X
ISSN (online)	1471-244X
ISSN	1471-244X
DOI	10.1186/s12888-022-03901-7
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Developing an inclusive Safe Dates program for sexual and gender minority adolescents: A pilot study.

Wesche, Rose / Galletly, Carol L / Shorey, Ryan C

Journal of adolescence

2020 Volume 86, Page(s) 11–14

Abstract: Introduction: Despite the prevalence and negative consequences of dating violence among sexual and gender minority (SGM) adolescents, few prevention programs address dating violence for these groups. We describe the adaptation of the evidence-based Safe ...

Abstract	Introduction: Despite the prevalence and negative consequences of dating violence among sexual and gender minority (SGM) adolescents, few prevention programs address dating violence for these groups. We describe the adaptation of the evidence-based Safe Dates dating violence prevention program to be inclusive of SGM adolescents and the outcome of a pilot trial of the expanded curriculum implemented in mixed settings serving both SGM and cisgender, heterosexual youth. Methods: Following a published framework of curriculum adaptation, we gathered information on SGM adolescents' needs and adapted Safe Dates materials to address SGM-specific risk factors for, and manifestations of, dating violence. We piloted the adapted program in 11 US schools and organizations serving SGM and cisgender, heterosexual youth (N = 156). The average age of participants was 15.11 years (SD = 2.76) at baseline. Participants were diverse with respect to race/ethnicity (26% Black/African American, 24% Hispanic/Latino, 21% White, 7% American Indian/Native Alaskan, 5% Asian/Pacific Islander), gender (56% female), and SGM status (35% SGM). Multi-level models measured change in scores on a written measure of dating violence knowledge from pre-test to post-test. Results: Dating violence knowledge increased significantly. Improvements did not differ by gender (female-identified versus not female-identified) or SGM status. Conclusions: Results support initial feasibility and efficacy of dating violence prevention programs that include both SGM and cisgender, heterosexual adolescents. The program normalizes diverse SGM identities and encourages participation of youth who are questioning or choosing not to disclose their gender or sexual identities. Larger-scale research should examine effects on dating violence experiences.
MeSH term(s)	Adolescent ; Female ; Gender Identity ; Heterosexuality ; Humans ; Male ; Pilot Projects ; Sexual Behavior ; Sexual and Gender Minorities
Language	English
Publishing date	2020-11-28
Publishing country	England
Document type	Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
ZDB-ID	303529-3
ISSN	1095-9254 ; 0140-1971
ISSN (online)	1095-9254
ISSN	0140-1971
DOI	10.1016/j.adolescence.2020.11.002
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.B 2093: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Barriers to drug treatment in police diversion programs and drug courts: A qualitative analysis.

Dickson-Gomez, Julia / Spector, Antoinette / Krechel, Sarah / Li, Jianghong / Montaque, Helena Danielle Green / Ohlrich, Jessica / Galletly, Carol / Weeks, Margaret

The American journal of orthopsychiatry

2022 Volume 92, Issue 6, Page(s) 692–701

Abstract	Drug treatment courts and police diversion programs are designed to divert people away from incarceration and into drug treatment. This article explores barriers in linking people who use drugs (PWUD) into drug treatment facilities in urban, suburban, and rural areas of Connecticut, Kentucky, and Wisconsin. Between December 2018 and March 2020, study teams in the three states conducted in-depth, semistructured interviews with key informants involved in programs to divert PWUD from criminal justice involvement including police, lawyers, judges, and others who work in drug treatment courts, and substance use disorder treatment providers who received referrals from and worked with police diversion programs or drug courts. Police diversion programs and drug treatment courts showed intraprogram variation in the structure of their programs in the three states and in different counties within the states. Structural barriers to successfully linking PWUD to treatment included a lack of resources, for example, a limited number of treatment facilities available, difficulties in funding mandated treatment, particularly in Wisconsin where Medicaid expansion has not occurred, and PWUDs' need for additional services such as housing. Many police officers, judges, and others within drug treatment court, including drug treatment specialists, hold stigmatizing attitudes toward medications to treat opioid use disorder (MOUD) and are unlikely to recommend or actively refer to MOUD treatment. Drug courts and police diversion programs offer a welcome shift from prior emphases on criminalization of drug use. However, for such programs to be effective, more resources must be dedicated to their success. (PsycInfo Database Record (c) 2022 APA, all rights reserved).
MeSH term(s)	United States ; Humans ; Police ; Substance-Related Disorders/therapy ; Criminal Law
Language	English
Publishing date	2022-10-13
Publishing country	United States
Document type	Journal Article
ZDB-ID	280031-7
ISSN	1939-0025 ; 0002-9432
ISSN (online)	1939-0025
ISSN	0002-9432
DOI	10.1037/ort0000643
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ui I Zs.228: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Does switching between high frequency rTMS and theta burst stimulation improve depression outcomes?

Chen, Leo / Thomas, Elizabeth H X / Kaewpijit, Pakin / Miljevic, Aleksandra / Hahn, Lisa / Lavale, Alexandra / Hoy, Kate E / Galletly, Cherrie / Fitzgerald, Paul B

Brain stimulation

2022 Volume 15, Issue 4, Page(s) 889–891

MeSH term(s)	Depression/therapy ; Depressive Disorder, Major ; Humans ; Theta Rhythm/physiology ; Transcranial Magnetic Stimulation ; Treatment Outcome
Language	English
Publishing date	2022-06-15
Publishing country	United States
Document type	Letter ; Research Support, Non-U.S. Gov't ; Comment
ZDB-ID	2394410-9
ISSN	1876-4754 ; 1935-861X
ISSN (online)	1876-4754
ISSN	1935-861X
DOI	10.1016/j.brs.2022.06.005
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 6740: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: "You're Not Supposed to be on it Forever": Medications to Treat Opioid Use Disorder (MOUD) Related Stigma Among Drug Treatment Providers and People who Use Opioids.

Dickson-Gomez, Julia / Spector, Antoinette / Weeks, Margaret / Galletly, Carol / McDonald, Madelyn / Green Montaque, Helena Danielle

Substance abuse : research and treatment

2022 Volume 16, Page(s) 11782218221103859

Abstract: Opioid use disorder (OUD) through prescription opioid misuse, heroin, and illicitly manufactured fentanyl use has increased dramatically in the past 20 years. Medications to treat opioid use disorder (MOUD) is considered the gold standard for treating ... ...

Abstract	Opioid use disorder (OUD) through prescription opioid misuse, heroin, and illicitly manufactured fentanyl use has increased dramatically in the past 20 years. Medications to treat opioid use disorder (MOUD) is considered the gold standard for treating opioid use disorders but uptake remains low. Recently, Madden has argued that in addition to the stigma assigned to substance use and people with SUD, MOUDs also are stigmatized, a process she labels
Language	English
Publishing date	2022-06-27
Publishing country	United States
Document type	Journal Article
ZDB-ID	1458030-5
ISSN	1547-0164 ; 1178-2218 ; 0889-7077
ISSN (online)	1547-0164
ISSN	1178-2218 ; 0889-7077
DOI	10.1177/11782218221103859
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 6243: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: The effects of propofol on heart rate, arterial pressure and adelta and C somatosympathetic reflexes in anaesthetized dogs.

Whitwam, J G / Galletly, D C / Ma, D / Chakrabarti, M K

European journal of anaesthesiology

2000 Volume 17, Issue 1, Page(s) 57–63

Abstract: The effects of propofol on mean arterial pressure, heart rate and Adelta and C somatosympathetic ... at rates from 0.4 to 2.0 mg kg-1 min-1. Mean C and Adelta reflexes were abolished at plasma concentrations ... Recovery of Adelta and C reflexes occurred at plasma concentrations of 13.1 (2.3) and 9.9 (1.3) microg mL-1 ...

Abstract	The effects of propofol on mean arterial pressure, heart rate and Adelta and C somatosympathetic reflexes, recorded in renal nerves, evoked by repeated individual supramaximal electrical stimuli applied to radial nerves, were observed in anaesthetized, paralysed and artificially ventilated dogs. Propofol was infused at rates from 0.4 to 2.0 mg kg-1 min-1. Mean C and Adelta reflexes were abolished at plasma concentrations (mean, SEM) of 24.3 (3.3) and 29.2 (2.6) microg mL-1 (P < 0.05), respectively, when mean arterial pressure and mean heart rate were reduced by approximately 55% (P < 0.01) and 26% (P > 0.05), respectively. Recovery of Adelta and C reflexes occurred at plasma concentrations of 13.1 (2.3) and 9.9 (1.3) microg mL-1 (P > 0.05), respectively. There was a log- arithmically linearly related fall in mean arterial pressure by 70% up to a plasma concentration approximately 97 microg mL-1 (r 2=0.7) with a 28% reduction in heart rate which was uncorrelated with the plasma concentrations (r 2=0.12). In conclusion, propofol abolished Adelta and C responses at comparable plasma concentrations and caused a major reduction in both mean arterial pressure and heart rate which is consistent with resetting of the baroreflexes. The reduction in mean arterial pressure was logarithmically, linearly correlated with a progressive increase in plasma concentrations without evidence of a ceiling effect.
MeSH term(s)	Anesthesia Recovery Period ; Anesthesia, Intravenous ; Anesthetics, Intravenous/administration & dosage ; Anesthetics, Intravenous/blood ; Anesthetics, Intravenous/pharmacology ; Animals ; Baroreflex/drug effects ; Blood Pressure/drug effects ; Dogs ; Electric Stimulation ; Evoked Potentials, Somatosensory/drug effects ; Heart Rate/drug effects ; Infusions, Intravenous ; Kidney/innervation ; Linear Models ; Nerve Fibers/drug effects ; Nerve Fibers, Myelinated/drug effects ; Neuromuscular Blockade ; Pilot Projects ; Propofol/administration & dosage ; Propofol/blood ; Propofol/pharmacology ; Radial Nerve/drug effects ; Radial Nerve/physiology ; Reflex/drug effects ; Respiration, Artificial ; Sympathetic Nervous System/drug effects
Chemical Substances	Anesthetics, Intravenous ; Propofol (YI7VU623SF)
Language	English
Publishing date	2000-01
Publishing country	England
Document type	Comparative Study ; Journal Article
ZDB-ID	605770-6
ISSN	1365-2346 ; 0265-0215
ISSN (online)	1365-2346
ISSN	0265-0215
DOI	10.1046/j.1365-2346.2000.00605.x
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 1955: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Peripheral NF-κB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-κB kinases.

Murphy, Caitlin E / Walker, Adam K / O'Donnell, Maryanne / Galletly, Cherrie / Lloyd, Andrew R / Liu, Dennis / Weickert, Cynthia Shannon / Weickert, Thomas W

Translational psychiatry

2022 Volume 12, Issue 1, Page(s) 21

Abstract: Elevations in plasma levels of pro-inflammatory cytokines and C-reactive protein (CRP) in patient ...

Abstract	Elevations in plasma levels of pro-inflammatory cytokines and C-reactive protein (CRP) in patient blood have been associated with impairments in cognitive abilities and more severe psychiatric symptoms in people with schizophrenia. The transcription factor nuclear factor kappa B (NF-κB) regulates the gene expression of pro-inflammatory factors whose protein products trigger CRP release. NF-κB activation pathway mRNAs are increased in the brain in schizophrenia and are strongly related to neuroinflammation. Thus, it is likely that this central immune regulator is also dysregulated in the blood and associated with cytokine and CRP levels. We measured levels of six pro-inflammatory cytokine mRNAs and 18 mRNAs encoding NF-κB pathway members in peripheral blood leukocytes from 87 people with schizophrenia and 83 healthy control subjects. We then assessed the relationships between the alterations in NF-κB pathway genes, pro-inflammatory cytokine and CRP levels, psychiatric symptoms and cognition in people with schizophrenia. IL-1β and IFN-γ mRNAs were increased in patients compared to controls (both p < 0.001), while IL-6, IL-8, IL-18, and TNF-α mRNAs did not differ. Recursive two-step cluster analysis revealed that high levels of IL-1β mRNA and high levels of plasma CRP defined 'high inflammation' individuals in our cohort, and a higher proportion of people with schizophrenia were identified as displaying 'high inflammation' compared to controls using this method (p = 0.03). Overall, leukocyte expression of the NF-κB-activating receptors, TLR4 and TNFR2, and the NF-κB subunit, RelB, was increased in people with schizophrenia compared to healthy control subjects (all p < 0.01), while NF-κB-inducing kinase mRNAs IKKβ and NIK were downregulated in patients (all p < 0.05). We found that elevations in TLR4 and RelB appear more related to inflammatory status than to a diagnosis of schizophrenia, but changes in TNFR2 occur in both the high and low inflammation patients (but were exaggerated in high inflammation patients). Further, decreased leukocyte expression of IKKβ and NIK mRNAs was unique to high inflammation patients, which may represent schizophrenia-specific dysregulation of NF-κB that gives rise to peripheral inflammation in a subset of patients.
MeSH term(s)	Anti-Inflammatory Agents ; Humans ; Inflammation ; NF-kappa B ; Neuroinflammatory Diseases ; Protein Serine-Threonine Kinases ; Schizophrenia ; NF-kappaB-Inducing Kinase
Chemical Substances	Anti-Inflammatory Agents ; NF-kappa B ; Protein Serine-Threonine Kinases (EC 2.7.11.1)
Language	English
Publishing date	2022-01-13
Publishing country	United States
Document type	Journal Article
ZDB-ID	2609311-X
ISSN	2158-3188 ; 2158-3188
ISSN (online)	2158-3188
ISSN	2158-3188
DOI	10.1038/s41398-021-01764-2
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Monitoring for post-injection delirium/sedation syndrome with long-acting olanzapine during the COVID-19 pandemic.

Siskind, Dan / Northwood, Korinne / Berk, Michael / Castle, David / Galletly, Cherrie / Harris, Anthony

The Australian and New Zealand journal of psychiatry

2020 Volume 54, Issue 7, Page(s) 759–761

MeSH term(s)	Antipsychotic Agents/adverse effects ; Australia/epidemiology ; Betacoronavirus ; COVID-19 ; Conscious Sedation/statistics & numerical data ; Coronavirus Infections/epidemiology ; Databases, Factual ; Delayed-Action Preparations/adverse effects ; Delirium/chemically induced ; Delirium/epidemiology ; Drug Monitoring/statistics & numerical data ; Humans ; Incidence ; Olanzapine/adverse effects ; Pandemics ; Pneumonia, Viral/epidemiology ; SARS-CoV-2 ; Syndrome
Chemical Substances	Antipsychotic Agents ; Delayed-Action Preparations ; Olanzapine (N7U69T4SZR)
Keywords	covid19
Language	English
Publishing date	2020-05-14
Publishing country	England
Document type	Letter
ZDB-ID	221140-3
ISSN	1440-1614 ; 0004-8674
ISSN (online)	1440-1614
ISSN	0004-8674
DOI	10.1177/0004867420927465
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 856: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

To top

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito